Literature DB >> 17285278

Successful treatment of avascular bone necrosis of the knee with neridronate: a case report.

A Corrado, L Quarta, S Errico, F P Cantatore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285278     DOI: 10.1007/s00296-007-0306-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


× No keyword cloud information.
  12 in total

1.  Alendronate in the treatment of avascular necrosis of the hip.

Authors:  S Agarwala; A Sule; B U Pai; V R Joshi
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

2.  The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

Authors:  Kuo-An Lai; Wun-Jer Shen; Chyun-Yu Yang; Chung-Jung Shao; Jui-Ting Hsu; Ruey-Mo Lin
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

3.  Effects of neridronate treatment in elderly women with osteoporosis.

Authors:  T Cascella; T Musella; F Orio; S Palomba; G Bifulco; C Nappi; G Lombardi; A Colao; L Tauchmanova
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

4.  The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment.

Authors:  M J Glimcher; J E Kenzora
Journal:  Clin Orthop Relat Res       Date:  1979-05       Impact factor: 4.176

5.  Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.

Authors:  David G Little; Michelle McDonald; Ian T Sharpe; Rachel Peat; Paul Williams; Tony McEvoy
Journal:  J Orthop Res       Date:  2005-02-25       Impact factor: 3.494

6.  Short-term intravenous therapy with Neridronate in Paget's disease.

Authors:  S Adami; M Bevilacqua; M Broggini; P Filipponi; S Ortolani; E Palummeri; F Ulivieri; F Nannipieri; V Braga
Journal:  Clin Exp Rheumatol       Date:  2002 Jan-Feb       Impact factor: 4.473

7.  Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.

Authors:  Harry K W Kim; Timothy S Randall; Haikuo Bian; Joe Jenkins; Amanda Garces; Frieder Bauss
Journal:  J Bone Joint Surg Am       Date:  2005-03       Impact factor: 5.284

8.  Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis.

Authors:  V Braga; D Gatti; F Colapietro; E Battaglia; D Righetti; R Prizzi; M Rossini; S Adami
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

Review 9.  Core decompression versus nonoperative management for osteonecrosis of the hip.

Authors:  M A Mont; J J Carbone; A C Fairbank
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

10.  Does alendronate prevent collapse in osteonecrosis of the femoral head?

Authors:  Takashi Nishii; Nobuhiko Sugano; Hidenobu Miki; Jun Hashimoto; Hideki Yoshikawa
Journal:  Clin Orthop Relat Res       Date:  2006-02       Impact factor: 4.176

View more
  5 in total

1.  [Therapy of bone marrow edema syndrome in the knee with denosumab. Case report].

Authors:  T Geith; W Mutschler; F Berger
Journal:  Unfallchirurg       Date:  2015-03       Impact factor: 1.000

2.  Inherited multicentric osteolysis: case report of three siblings treated with bisphosphonate.

Authors:  Senq-J Lee; Colin Whitewood; Kevin J Murray
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-17       Impact factor: 3.054

3.  Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial.

Authors:  C Meier; C Kraenzlin; N F Friederich; T Wischer; L Grize; C R Meier; M E Kraenzlin
Journal:  Osteoporos Int       Date:  2013-11-22       Impact factor: 4.507

4.  Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain.

Authors:  Josep Darbà; Lisette Kaskens; Francesc Sorio Vilela; Mickael Lothgren
Journal:  Clinicoecon Outcomes Res       Date:  2015-02-09

5.  Zoledronic acid for the treatment of pregnancy-associated femoral head necrosis: A case report.

Authors:  Estella Musacchio; Leonardo Sartori
Journal:  Case Rep Womens Health       Date:  2020-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.